Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Sales | 300 | 343 | 355 | 555 | 596 |
| Gross Profit | 300 | 343 | 355 | 555 | 596 |
| Operating Expenses | 29,683 | 33,685 | 26,046 | 26,481 | 29,732 |
| Operating Income | -29,383 | -33,342 | -25,691 | -25,926 | -29,136 |
| Interest Expense | 537 | 551 | 560 | 810 | 607 |
| Other Income | 52 | 48 | 148 | 98 | 114 |
| Pre-tax Income | -29,868 | -33,845 | -26,103 | -26,638 | -29,629 |
| Net Income Continuous | -29,868 | -33,845 | -26,103 | -26,638 | -29,629 |
| Net Income | $-29,868 | $-33,845 | $-26,103 | $-26,638 | $-29,629 |
| EPS Basic Total Ops | -0.42 | -0.63 | -0.56 | -0.56 | -0.63 |
| EPS Basic Continuous Ops | -0.44 | -0.68 | -0.54 | -0.55 | -0.61 |
| EPS Diluted Total Ops | -0.42 | -0.63 | -0.56 | -0.56 | -0.63 |
| EPS Diluted Continuous Ops | -0.44 | -0.68 | -0.54 | -0.55 | -0.61 |
| EBITDA(a) | $-28,258 | $-32,207 | $-24,510 | $-24,662 | $-27,829 |